Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice

Nature

Volumn 377, Issue 6551, 1995, Pages 744-747

  Hein, Lutz ^a   Barsh, Gregory S ^b   Pratt, Richard E ^a   Dzau, Victor J ^a   Kobilka, Brian K ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ALDOSTERONE RELEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRINKING; ELECTROLYTE BALANCE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FLUID BALANCE; LOCOMOTION; MALE; MOUSE; MUTANT; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WATER DEPRIVATION;

ANGIOTENSIN II; ANIMAL; BEHAVIOR, ANIMAL; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CELL LINE; CLONING, MOLECULAR; DRINKING BEHAVIOR; EMBRYO AND FETAL DEVELOPMENT; FEMALE; HEART RATE; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTAGENESIS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VASOCONSTRICTOR AGENTS;

EID: 0028885773     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/377744a0     Document Type: Article

References (30)

1. Kambayashi, Y., et al. J. biol. Chem. 268, 24543-24546 (1993).
2. Mukoyama, M., et al. J. biol. Chem. 268, 24539-24542 (1993).
3. Zhuo, et al. in Hypertension: Pathophysiology, Diagnosis, and Management (eds Laragh, J. H, & Brenner, B. M.) 1739-1762 (Raven, New York, 1995).
4. Grady, E. F., Sechi, L. A., Griffin, C. A., Schambelan, M. & Kalinyak, J. E. J. clin. Invest. 88, 921-933 (1991).
5. Chassagne, C., Beatty, B. G. & Meloche, S. Genomics 25, 601-603 (1995).
6. Koike, G., et al. Biochem. biophys. Res. Commun. 203, 1842-1850 (1994).
7. Feuillan, P. P., Millan, M. A. & Aguilera, G. Regul. Pept. 44, 159-169 (1993).
8. Wright, J. W. & Harding, J. W. Neurosci. Biobehav. Rev. 18, 21-53 (1994).
9. Cooney, A. S. & Fitzsimons, J. T. Expl Physiol. 78, 767-774 (1993).
10. Hogarty, D. C., Speakman, E. A., Puig, V. & Phillips, M. I. Brain Res. 586, 289-294 (1992).
11. Rowland, N. E., Rozelle, A., Riley, P. J. & Fregly, M. J. Brain Res. Bull. 29, 389-393 (1992).
12. Rowland, N. E. & Fregly, M. J. Brain Res. Bull. 32, 391-394 (1993).
13. Dourish, C. T., Duggan, J. A. & Banks, R. J. Eur. J. Pharmac. 211, 113-116 (1992).
14. Georgiev, V. Pol. J. Pharmac. Pharm. 42, 553-562 (1990).
15. Georgiev, V., Getova, D. & Opitz, M. Meth. Find. Exp. Clin. Pharmac. 13, 5-9 (1991).
16. Petkova, B., Georgiev, V. & Kambourova, T. Acta Physiol. Pharmac. Bulg. 17, 84-90 (1991).
17. Rowe, B. P., Saylor, D. L. & Speth, R. C. Neuroendocrinology 55, 563-573 (1992).
18. Tsutsumi, K. & Saavedra, J. M. Molec Pharmac. 41, 290-297 (1992).
19. Sumners, C. & Phillips, M. I. Am. J. Physiol. 244, R257-R263 (1983).
20. Huang, Y., Rogers, J. & Henderson, G. J. Neurochem. 49, 1541-1549 (1987).
21. Ichicki, T., et al. Nature 377, 748-750 (1995).
22. Viswanathan, M., Stromberg, C., Seltzer, A. & Saavedra, J. M. J. clin. Invest. 90, 1707-1712 (1992).
23. Lopez, J. J., et al. Am. J. Physiol. H844-H852 (1994).
24. Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M. & Inada, M. J. clin. Invest. 95, 46-54 (1995).
25. Grady, E. F. & Kalinyak, J. E. Regul. Pept. 44, 171-180 (1993).
26. Nakajima, M., Mukoyama, M., Pratt, R. E., Horiuchi, M. & Dzau, V. J. Biochem. biophys. Res. Commun. 197, 393-399 (1993).
27. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Cell 64, 693-702 (1991).
28. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J. C. Proc. natn. Acad. Sci. U.S.A. 90, 8424-8428 (1993).
29. Wood, S. A., Allen, N. D., Rossant, J., Auerbach, A. & Nagy, A. Nature 365, 87-89 (1993).
30. Xu, M., et al. Cell 79, 945-955 (1994).